Logo image
Late-breaking abstract 2: Bevacizumab shows activity in treating recurrent sex cord-stromal ovarian tumors: Results of a phase II trial of the Gynecologic Oncology Group
Abstract   Peer reviewed

Late-breaking abstract 2: Bevacizumab shows activity in treating recurrent sex cord-stromal ovarian tumors: Results of a phase II trial of the Gynecologic Oncology Group

J. Brown, W. Brady, J. Schink, L. Van Le, M. Leitao, S. Yamada, K De Geest and D. Gershenson
Gynecologic oncology, Vol.125(3), pp.771-772
06/01/2012
DOI: 10.1016/j.ygyno.2012.03.035

View Online

Abstract

Obstetrics and Gynecology

Details

Metrics

28 Record Views
Logo image